Perioperative Anticoagulation Management — MCQs

10 questions

A 20-year-old woman with a family history of von Willebrand disease is found to have an activated partial thromboplastin time (aPTT) of 78 (normal = 32) on routine testing prior to cholecystectomy. Further investigation reveals a prothrombin time (PT) of 13 (normal = 12), a platelet count of 350,000/mm³, and an abnormal bleeding time. Which of the following should be administered in the perioperative period?

Which of the following drugs need not be stopped before surgery?

Which of the following drugs is a direct inhibitor of clotting factor Xa?

Arrange the following anticoagulant drugs in ascending order (shortest to longest) based on the pre-operative cessation time before surgery: 1) Clopidogrel 2) Ticlopidine 3) Low molecular weight heparin 4) Warfarin

What is the most appropriate perioperative management regarding the antihypertensive medication of a 55-year-old male with a history of hypertension who has been taking ACE inhibitors for the past 5 years and is scheduled for elective hernia repair surgery?

Which of the following signs of congestive cardiac failure constitute a major risk to the surgical patient undergoing anaesthesia ?

Deep vein thrombosis of calf is best managed by :

A patient with native aortic valve disease presents with right hemiparesis. What is the most appropriate management to prevent further strokes?

What is the initial management for a stable patient with atrial fibrillation?

Q10

Best immediate management of hyperkalemia includes all except?

Perioperative Anticoagulation Management Indian Medical PG Practice Questions and MCQs

Question 1: A 20-year-old woman with a family history of von Willebrand disease is found to have an activated partial thromboplastin time (aPTT) of 78 (normal = 32) on routine testing prior to cholecystectomy. Further investigation reveals a prothrombin time (PT) of 13 (normal = 12), a platelet count of 350,000/mm³, and an abnormal bleeding time. Which of the following should be administered in the perioperative period?

A. Factor VIII
B. Desmopressin (DDAVP) (Correct Answer)
C. Platelets
D. Vitamin K

Explanation: ***Desmopressin (DDAVP)*** - **Desmopressin** is the first-line treatment for **von Willebrand disease (vWD)** [1], especially for type 1, which this patient's profile suggests (prolonged aPTT, normal PT, normal platelet count, and abnormal bleeding time). - It works by stimulating the release of endogenous **von Willebrand factor (vWF)** and **factor VIII** from endothelial cells [1]. *Factor VIII* - While Factor VIII deficiency can cause prolonged aPTT, this patient's presentation with a family history of **vWD**, normal PT, and abnormal bleeding time points specifically to a **vWF** defect rather than isolated **Factor VIII** deficiency [1]. - Administration of direct **Factor VIII** is not the primary treatment for **vWD**, although vWF concentrate (which contains Factor VIII) may be used for severe cases [1]. *Platelets* - The patient's **platelet count is normal** (350,000/mm³), indicating that a platelet transfusion is not necessary. - **vWD** is a disorder of platelet adhesion, not a problem with platelet quantity. *Vitamin K* - **Vitamin K** is essential for the synthesis of coagulation factors II, VII, IX, and X, as well as proteins C and S. - A deficiency in **Vitamin K** typically results in a prolonged **PT** [2], which is normal in this patient.

Question 2: Which of the following drugs need not be stopped before surgery?

A. High Dose Aspirin
B. Metformin
C. Digitalis (Correct Answer)
D. Warfarin

Explanation: ***Digitalis*** - **Digitalis (digoxin)** is often continued through surgery, especially in patients with **heart failure** or **atrial fibrillation** to maintain cardiac function. - Its cessation could precipitate **cardiac decompensation** or arrhythmias, which are high-risk events during surgery. *High Dose Aspirin* - **High-dose aspirin** should generally be stopped before surgery due to its **antiplatelet effects**, increasing the risk of perioperative bleeding. - The duration of discontinuation depends on the type of surgery and individual patient risk. *Metformin* - **Metformin** should be stopped before surgery due to the risk of **lactic acidosis**, especially in situations involving **renal impairment** or hypoperfusion associated with surgery. - It's typically held on the day of surgery and for 24-48 hours post-operatively, depending on renal function. *Warfarin* - **Warfarin** is a strong oral anticoagulant that must be discontinued before most surgeries to prevent **excessive bleeding**. - It is typically stopped 5 days pre-op, and patients often receive **bridging therapy** with heparin, depending on their risk for thromboembolism.

Question 3: Which of the following drugs is a direct inhibitor of clotting factor Xa?

A. Argatroban
B. Fondaparinux
C. Apixaban (Correct Answer)
D. Aspirin

Explanation: ***Apixaban*** - Apixaban is an **oral direct factor Xa inhibitor**, which means it directly binds to and inactivates factor Xa. - This inhibition prevents the conversion of **prothrombin to thrombin**, thereby disrupting the coagulation cascade. *Argatroban* - Argatroban is a **direct thrombin inhibitor** (DTI), meaning it selectively binds to and inhibits thrombin (factor IIa). - It is often used in cases of **heparin-induced thrombocytopenia (HIT)** due to its non-heparin-based mechanism of action. *Fondaparinux* - Fondaparinux is an **indirect factor Xa inhibitor** that binds to antithrombin, thereby enhancing antithrombin's ability to inactivate factor Xa. - It does not directly bind to factor Xa itself, but rather potentiates the action of a natural anticoagulant. *Aspirin* - Aspirin is an **antiplatelet agent** that inhibits cyclooxygenase (COX-1), thereby reducing the production of thromboxane A2. - This mechanism primarily inhibits **platelet aggregation** and adhesion, rather than directly inhibiting a clotting factor in the coagulation cascade.

Question 4: Arrange the following anticoagulant drugs in ascending order (shortest to longest) based on the pre-operative cessation time before surgery: 1) Clopidogrel 2) Ticlopidine 3) Low molecular weight heparin 4) Warfarin

A. 2>1>3>4
B. 4>3>2>1
C. 3>4>1>2 (Correct Answer)
D. 3>4>2>1

Explanation: ***3>4>1>2*** - The correct order, in ascending time from last dose to surgery, is **low molecular weight heparin (LMWH)** (12-24 hours), **warfarin** (5 days), **clopidogrel** (5-7 days), and **ticlopidine** (10-14 days). - This order reflects the varying half-lives and durations of action of these anticoagulants and antiplatelet agents. *2>1>3>4* - This order is incorrect as it places **ticlopidine** (longest withdrawal) before **clopidogrel** despite ticlopidine having a much longer recommended withdrawal period. - It also misplaces **LMWH** and **warfarin** in relation to the antiplatelet agents. *4>3>2>1* - This order incorrectly positions **warfarin** (5 days) as having the longest pre-surgical hold time, though it is shorter than ticlopidine and clopidogrel. - It also improperly orders the antiplatelets and **LMWH** with regard to their pre-operative cessation periods. *3>4>2>1* - This order incorrectly places **ticlopidine** after **clopidogrel**, when ticlopidine requires a significantly longer cessation period prior to surgery. - It correctly places **LMWH** and **warfarin** relative to each other, but the antiplatelet order is wrong.

Question 5: What is the most appropriate perioperative management regarding the antihypertensive medication of a 55-year-old male with a history of hypertension who has been taking ACE inhibitors for the past 5 years and is scheduled for elective hernia repair surgery?

A. Switch to a beta-blocker 48 hours before surgery
B. Continue ACE inhibitors until the morning of surgery (Correct Answer)
C. No changes needed in his medication regimen
D. Discontinue ACE inhibitors 24 hours prior to surgery to avoid hypotension.

Explanation: ***Continue ACE inhibitors until the morning of surgery*** - While it's common practice to hold ACE inhibitors on the day of surgery to prevent **intraoperative hypotension**, continuing them until the morning of surgery is often acceptable for elective procedures as it minimizes the risk of **rebound hypertension**. - Following the most recent guidelines, for patients undergoing elective non-cardiac surgery, ACE inhibitors can be continued, but it is important to check the specific institutional guidelines as the decision to hold or continue ACE inhibitors often varies based on the patient's individual risk profile and the type of surgery. *Switch to a beta-blocker 48 hours before surgery* - Switching to a beta-blocker acutely before surgery without a clear indication could lead to **uncontrolled hypertension** or other adverse effects if the patient is not accustomed to beta-blockers. - Beta-blockers are generally continued perioperatively if the patient is already taking them, but initiating them immediately before surgery is not a standard recommendation for routine hypertension management. *No changes needed in his medication regimen* - This is incorrect as current guidelines suggest at least some modification, such as holding the ACE inhibitor on the morning of surgery due to the risk of **refractory hypotension** under anesthesia. - ACE inhibitors can interact with anesthetic agents, making blood pressure management more challenging during surgery. *Discontinue ACE inhibitors 24 hours prior to surgery to avoid hypotension.* - While recommended by some older guidelines and for certain high-risk patients, discontinuing ACE inhibitors 24 hours prior is not universally recommended for all elective surgeries as it may increase the risk of **perioperative hypertension** or rebound effects. - The risk of perioperative hypotension with ACE inhibitors is real, however, in an elective setting, the current trend is to hold the dose on the morning of the surgery rather than a day before unless institution specific guidelines explicitly mention it.

Question 6: Which of the following signs of congestive cardiac failure constitute a major risk to the surgical patient undergoing anaesthesia ?

A. Pedal oedema
B. Jugular venous distention and third heart sound (Correct Answer)
C. Basal crepitations on auscultation
D. Cardiomegaly

Explanation: ***Jugular venous distention and third heart sound*** - **Jugular venous distention (JVD)** indicates elevated right atrial pressure and **central venous pressure**, signifying significant volume overload and potential right ventricular dysfunction. - A **third heart sound (S3)** is a strong indicator of **ventricular dysfunction** and high filling pressures, suggesting severe heart failure and poor cardiac reserve, which poses a major risk during anesthesia. *Pedal oedema* - **Pedal edema** can be a sign of fluid overload, but it is a relatively mild and chronic symptom of heart failure compared to acute decompensation. - While it reflects increased hydrostatic pressure, it doesn't alone signify the immediate, critical hemodynamic instability that poses a major perioperative risk. *Basal crepitations on auscultation* - **Basal crepitations** (rales) suggest **pulmonary congestion** due to left ventricular failure, indicating fluid in the small airways. - Although concerning, this sign primarily reflects lung involvement and not necessarily the critical, global hemodynamic compromise indicated by JVD and S3. *Cardiomegaly* - **Cardiomegaly** (enlarged heart) is an imaging finding that reflects chronic cardiac remodeling due to long-standing heart disease. - It indicates a history of heart failure but does not directly reflect the **acute hemodynamic status** and immediate risk of decompensation during surgery.

Question 7: Deep vein thrombosis of calf is best managed by :

A. active physiotherapy
B. anticoagulants (Correct Answer)
C. thrombolysis
D. surgical venous thrombectomy

Explanation: ***Anticoagulants*** - **Anticoagulation** therapy is the cornerstone of DVT management, preventing clot extension and reducing the risk of **pulmonary embolism** [1]. - Medications like **heparin**, **low molecular weight heparin**, or **direct oral anticoagulants (DOACs)** are commonly used [1]. *active physiotherapy* - While physical activity can prevent DVT, it is generally **contraindicated in acute DVT** due to the risk of dislodging the clot. - Mobilization is introduced gradually once anticoagulation is therapeutic and the risk of **embolization** is reduced. *thrombolysis* - **Thrombolysis** (clot dissolution) is usually reserved for **proximal, extensive DVT** [1] or DVT with **limb-threatening ischemia** [2]. - It carries a **higher risk of bleeding** compared to anticoagulation and is not typically necessary for isolated calf DVT [2]. *surgical venous thrombectomy* - **Surgical thrombectomy** is rarely performed for DVT and is generally reserved for **massive iliocaval thrombosis** with severe limb threat. - It is an **invasive procedure** with significant risks and is not indicated for typical calf DVT.

Question 8: A patient with native aortic valve disease presents with right hemiparesis. What is the most appropriate management to prevent further strokes?

A. Both antiplatelet and anticoagulant
B. One dose of low molecular weight heparin sub-cutaneously followed by dual antiplatelet therapy
C. Antiplatelet only
D. Anticoagulant only (Correct Answer)

Explanation: ***Anticoagulant only*** - Patients with **native aortic valve disease** and **embolic stroke (like right hemiparesis)** are at high risk for further strokes if the emboli are cardiogenic in origin, often from valvular vegetations or abnormalities [1]. **Anticoagulants** are superior to antiplatelets in preventing recurrent **systemic embolization** from cardiac sources. - While the specific cause of the aortic valve disease isn't stated (e.g., infective endocarditis, nonbacterial thrombotic endocarditis, or calcific aortic stenosis with mobile thrombus), **anticoagulation** is generally the preferred strategy in this context to prevent further **thromboembolic events**. *Antiplatelet only* - **Antiplatelet agents** (e.g., aspirin, clopidogrel) primarily prevent arterial clots formed on atherosclerotic plaques and are less effective for preventing **cardiogenic emboli** originating from valvular disease. - Relying solely on antiplatelet therapy in this scenario would leave the patient at a higher risk for recurrent strokes from the underlying **cardiac source** [1]. *Both antiplatelet and anticoagulant* - While some conditions warrant combination therapy (e.g., after certain cardiac procedures or in specific acute coronary syndromes), adding an **antiplatelet agent** to an **anticoagulant** significantly increases the risk of **bleeding** without providing substantial additional benefit for preventing stroke in the context of native aortic valve disease as the primary stroke mechanism. - The increased **bleeding risk** generally outweighs the potential benefit for preventing future strokes when the primary etiology points to cardiogenic embolism. *One dose of low molecular weight heparin sub-cutaneously followed by dual antiplatelet therapy* - A single dose of **LMWH** provides short-term anticoagulation and is not sufficient for long-term stroke prevention in a patient with ongoing risk from native aortic valve disease. - **Dual antiplatelet therapy (DAPT)** is indicated in other contexts (e.g., after stent placement) but is not the appropriate long-term strategy for preventing **cardiogenic strokes** from valvular disease, where anticoagulation is paramount.

Question 9: What is the initial management for a stable patient with atrial fibrillation?

A. Rhythm control
B. Rate control (Correct Answer)
C. Cardioversion
D. Anticoagulation

Explanation: ***Rate control*** - In a **stable patient** with atrial fibrillation, the initial management strategy focuses on controlling the ventricular rate to alleviate symptoms and improve cardiac output, often using **beta-blockers** or **calcium channel blockers** [1]. - This approach is preferred over rhythm control as a first step due to fewer side effects and similar long-term outcomes in many stable cases. *Rhythm control* - This strategy aims to restore and maintain **normal sinus rhythm**, often via **antiarrhythmic drugs** or **catheter ablation** [3]. - While beneficial for some, it is typically considered after rate control, especially if symptoms persist or if the patient is symptomatic despite adequate rate control [1]. *Cardioversion* - This is an immediate intervention to restore **normal sinus rhythm** through electrical shock or pharmacologic agents. - It's usually reserved for **hemodynamically unstable** patients or after assessing the risk of thromboembolism, making it inappropriate as the initial step for a stable patient. *Anticoagulation* - This is critical for preventing **thromboembolic events**, particularly strokes, in patients with atrial fibrillation [2]. - While essential in the overall management plan, it is not the initial treatment strategy for managing the immediate cardiac symptoms of AF itself, but rather for **stroke prevention**.

Question 10: Best immediate management of hyperkalemia includes all except?

A. Salbutamol nebulization
B. Insulin drip
C. Calcium gluconate
D. MgSO4 (Correct Answer)

Explanation: ***MgSO4*** - **Magnesium sulfate** is not used for the immediate management of **hyperkalemia**; its primary uses include treating hypomagnesemia, eclampsia, and certain arrhythmias. - While magnesium can have effects on electrolyte balance, it directly addresses calcium or potassium levels in an acute hyperkalemic crisis. *Calcium gluconate* - **Calcium gluconate** is crucial for **cardiac stabilization** in hyperkalemia by protecting the myocardium from potassium's effects [1]. - It does not lower potassium levels but prevents life-threatening arrhythmias by antagonizing the cardiac membrane effects of potassium [1]. *Insulin drip* - An **insulin drip** (often with dextrose) shifts potassium **intracellularly**, thereby lowering serum potassium levels [1]. - This effect is rapid, making it an effective measure for immediate management. *Salbutamol nebulization* - **Salbutamol (albuterol)** nebulization can also help shift potassium into cells, thus reducing serum potassium levels. - It works by stimulating beta-2 adrenergic receptors, which activate the **Na+/K+-ATPase pump**.

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free